A summary of the belt-tightening state of Big Pharma right now, from Med Ad News. From ABC, Ten Health Advances that have changed the world. Americans trust the FDA more than pharma …
Pharma News 9_14
Prasugrel, the upcoming rival to $6 billion drug Plavix, gets a write-up. This is a crucial new drug for co-promote partners Daiichi-Sankyo and Eli Lilly. Good Samaritan drug rep loses leg, gains …
Pharma News 8_30
On the Oncology front... Bayer's Nexavar shows encouraging results: Bayer and Onyx Pharmaceuticals said they were stopping a late clinical liver cancer trial with Nexavar in the Asia-Pacific region …
Pharma News 8_17
Amgen finally feels the heat from declining market demand; big cuts coming. Novartis takes a hit on Prexige (COX-2 inhibitor); withdrawn in Australia. New cancer killers? Electric fields, gene …
Pharma News 8_3
A minor comeback for Novartis' Zelnorm. Avandia gets a reprieve, of sorts...to remain on the market, but undoubtedly with a raft of warnings and cautions. Meanwhile, more encouraging data on Actos, …
Pharma News 7_27
Two weeks worth of news articles linked here: Medical News Actos: safer than Avandia? Cialis going toward a once-daily version (but shouldn't it be once every day-and-a-half??) Novartis gets some …